Clinical Trial Update: A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for ARRY-371797 in LMNA-related dilated cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lmna-related Dilated Cardiomyopathy

Drugs mentioned

• ARRY-371797

Snippet

Sponsor: Pfizer | Conditions: LMNA-Related Dilated Cardiomyopathy | Phase 2 | Status: COMPLETED